Tag: ivermectin

Ivermectin administration is associated with lower gastrointestinal complications and greater ventilator-free days in ventilated patients with COVID-19: A propensity score analysis – ScienceDirect
— Read on www.sciencedirect.com/science/article/abs/pii/S1341321X21003603

Evidence in favour of Ivermectin for treatment of Covid-19 keeps stacking up.

For the 24 states with early IVM treatment (and Lima), excess deaths dropped 59% (25%) at +30 days and 75% (25%) at +45 days after day of peak deaths. Case fatalities likewise dropped sharply in all states but Lima, yet six indices of Google-tracked community mobility rose over the same period. For nine states having mass distributions of IVM in a short timeframe through a national program, Mega-Operación Tayta (MOT), excess deaths at +30 days dropped by a population-weighted mean of 74%, each drop beginning within 11 day after MOT start. Extraneous causes of mortality reductions were ruled out. These sharp major reductions in COVID-19 mortality following IVM treatment thus occurred in each of Peru’s states, with such especially sharp reductions in close time conjunction with IVM treatments in each of the nine states of operation MOT. Its safety well established even at high doses, IVM is a compelling option for immediate, large scale national deployments as an interim measure and complement to pandemic control through vaccinations.

Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments

Allow me to be blunt, but at this point in time, anyone denying that HCQ-based protocols are effective is either a total ignorant or an evil liar. There’s just too much evidence. As Dr McCullough said, there’s only 1 in 17 billion chances that HCQ doesn’t work for Covid-19.

However, evidence for the even superior efficacy of Ivermectin is mounting quickly.

The video below and the accompanying post are worth your time.